ONIVYDE liposomal pégylé 43 mg/10ml flac

7680659940037 CH-65994 L01CE02 07.16.1.
ONIVYDE liposomal pégylé 43 mg/10ml flac
ONIVYDE liposomal pégylé 43 mg/10ml flac
ONIVYDE liposomal pégylé 43 mg/10ml flac
1 / 3
google

Details

Product number
6599401
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
irinotecanum 43 mg ut irinotecani sucrosofas corresp. irinotecani hydrochloridum trihydricum 50 mg, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, acidum hydroxyethylpiperazinethansulfonicum, natrii chloridum corresp. natrium 33.1 mg, aqua ad iniectabile q.s. ad solutionem pro 10 ml.

Articles (1)

Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion
dispersion à diluer pour perfusion
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
23/10/2024
Professional SmPC
Français
23/10/2024
Professional SmPC
Italien
23/10/2024

Detailed composition

Substance Quantity Type Category
(N/A)
43.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
50.0 MG Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
33.1 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

Servier (Suisse) SA

1202 Genève

Authorization information

Swissmedic authorization number
65994
Drug name
Onivyde liposomal pégylé 4.3 mg/ml, dispersion à diluer pour perfusion
Galenic form
KOIND
ATC Code
L01CE02
Authorization status
Z
Dispensation category
A
First authorization
25/07/2017
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Metastasiertes Adenokarzinom des Pankreas

Packaging details

Description (FR)
ONIVYDE liposomal pégylé 43 mg/10ml flac
Description (DE)
ONIVYDE liposomal pégylé 43 mg/10ml Durchstf
Market launch
25/07/2017
Narcotic (BTM)
No

Available generics

Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 57.25
View
Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 115.40
View
Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 283.55
View
Irinotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
CHF 405.70
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 57.60
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 116.25
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 283.55
View
Irinotecan Sandoz eco, Konzentrat zur Herstellung einer Infusionslösung
CHF 410.50
View
Irinotecan-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
CHF 57.85
View
Irinotecan-Teva liquid, Konzentrat zur Herstellung einer Infusionslösung
CHF 115.85
View

Other packaging sizes